Infectious bovine keratoconjunctivitis (IBK) is an economically important disease of beef cattle. Currently, there is little public evidence from randomized controlled trials that the different vaccines and vaccination regimes available to prevent IBK in cattle are effective, including autogenous and commercial vaccines directed at Moraxella bovis or Moraxella bovoculi. The combined use of a commercial M. bovis (CMB) vaccine and a conditionally licensed M. bovoculi vaccine (CLMB) has yet to be publicly evaluated.
No takes yet. Share an insight, caveat, or question.
Clark et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: